globus medical nevro - Search News

Nevro, Globus

Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients

Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain,

MassDevice · 1d

Globus Medical to acquire Nevro for $250M

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

Seeking Alpha on MSN · 2d

Globus Medical to buy Nevro in $250M all-cash deal

Globus Medical (NYSE:GMED) said it has agreed to buy Nevro (NVRO) through an all-cash deal with an equity value of around $250M. Under the deal, Globus Medical (NYSE:GMED) will buy all of Nevro's (NVRO) stock for $5.

1don MSN

Piper Sandler raises Nevro stock to Neutral, cuts target to $5.85

Piper Sandler analyst Adam Maeder upgraded shares of Nevro Corp (NYSE:NVRO), a medical device company with a market ...

Zacks.com on MSN1d

Nevro (NVRO) Soars 13.9%: Is Further Upside Left in the Stock?

Nevro (NVRO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

23h

Nevro upgraded to Hold from Underperform at Jefferies

Jefferies upgraded Nevro (NVRO) to Hold from Underperform with a price target of $5.85, up from $4.50, after the company entered into a ...

TMCnet2d

Shareholder Alert: Ademi & Fruchter LLP Investigates Whether Nevro Corp. Is Obtaining a Fair Price for Its Public Shareholders

Ademi & Fruchter LLP is investigating Nevro (NYSE: NVRO) for possible breaches of fiduciary duty and other violations of law in its transaction with Globus Medical.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results